Abstract 5191: BCL-2 inhibitor APG-2575 promotes anti-tumor immunity through converting tumor-associated macrophages into M1 phenotype in non-small cell lung cancer

Authors: Fan Luo, Fei-teng Lu, Miao-zhen Qiu, Wen-tao Pan, Lin Zhang, Hong-yun Zhao, Li Zhang, Da-jun Yang

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-5191

Source: Full article


Abstract

Abstract